Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Salemi

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2013
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up studyL Lavorgna, S Bonavita, D Ippolito, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Cognitive dysfunction in patients with relapsing-remitting multiple sclerosisU Nocentini, P Pasqualetti, S Bonavita, et al.
Neurology|November 15, 2011
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantroneV Martinelli, E Cocco, R Capra, et al.
European Journal of Neurology|July 2, 2009
An exploration of anger phenomenology in multiple sclerosisU Nocentini, G Tedeschi, R Migliaccio, et al.
Annals of Neurology|October 23, 2009
Real-life impact of early interferon beta therapy in relapsing multiple sclerosisM Trojano, F Pellegrini, D Paolicelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 29, 2013
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 casesA Ghezzi, P Annovazzi, E Cocco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2008
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up studyG Tedeschi, D Dinacci, M Comerci, et al.
Neurology|July 27, 2005
Brain atrophy and lesion load in a large population of patients with multiple sclerosisG Tedeschi, L Lavorgna, P Russo, et al.
Journal of the Neurological Sciences|July 21, 2009
Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatmentM Trojano, F Pellegrini, D Paolicelli, et al.
Neurology|April 13, 2005
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severityR H S R Roxburgh, S R Seaman, T Masterman, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2013
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up studyL Lavorgna, S Bonavita, D Ippolito, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Cognitive dysfunction in patients with relapsing-remitting multiple sclerosisU Nocentini, P Pasqualetti, S Bonavita, et al.
Neurology|November 15, 2011
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantroneV Martinelli, E Cocco, R Capra, et al.
European Journal of Neurology|July 2, 2009
An exploration of anger phenomenology in multiple sclerosisU Nocentini, G Tedeschi, R Migliaccio, et al.
Annals of Neurology|October 23, 2009
Real-life impact of early interferon beta therapy in relapsing multiple sclerosisM Trojano, F Pellegrini, D Paolicelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 29, 2013
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 casesA Ghezzi, P Annovazzi, E Cocco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2008
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up studyG Tedeschi, D Dinacci, M Comerci, et al.
Neurology|July 27, 2005
Brain atrophy and lesion load in a large population of patients with multiple sclerosisG Tedeschi, L Lavorgna, P Russo, et al.
Journal of the Neurological Sciences|July 21, 2009
Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatmentM Trojano, F Pellegrini, D Paolicelli, et al.
Neurology|April 13, 2005
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severityR H S R Roxburgh, S R Seaman, T Masterman, et al.
Pageof 7